Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Recruiting · NCT07197645 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain | Neoplasms by Site, bone disorder, musculoskeletal system disorder, neoplasm | Recruiting | Phase 1 | 2026-05-14 | NCT07197645 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Telix Pharmaceuticals (Innovations) Pty Limited | 11 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Biogenix Molecular, LLC, CIRA Health | Miami | United States | 1 |
| Excel Diagnostics and Nuclear Oncology Center | Houston | United States | 5 |
| Houston Metro Urology | Houston | United States | 27 |
| NovaCure | Miami | United States | 1 |
| Oncology Consultants | Houston | United States | 22 |
| University of Texas Medical Branch at Galveston (UTMB) | Houston | United States | 1 |